June 5, 2026 · Pediatric blood & cancer · DOI: 10.1002/1545-5017.70414

The Role of Hematopoietic Cell Transplantation in Ataxia-Telangiectasia

Listen to this summary

The authors investigate the role of hematopoietic cell transplantation (HCT) in treating ataxia-telangiectasia (A-T), a condition characterized by immunodeficiency and cancer predisposition. They review existing literature on HCT outcomes, conditioning regimens, and associated toxicities, finding that reduced-intensity regimens are better tolerated and more effective than myeloablative approaches. The study concludes that while HCT may benefit select high-risk A-T patients, further research and collaboration are necessary to establish best practices.

Laila Alkhouli, Seth Rotz, Masatoshi Takagi, Richa Sharma

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play